equicenta® CTM is produced under a quality management system built on our guiding principle, “Horse First, Sport Second.” That means every step—from donor herd management and umbilical cord collection to processing, batch-level identity testing, and ongoing clinical evaluation—is designed to put equine welfare, scientific rigor, and regulatory transparency ahead of short-term trends.
Our goal is to set a benchmark for how animal cell- and tissue-based products should be developed, overseen, and used in horse medicine. We are ISO 13485 certified and follow FDA CVM Guidance for Industry #218, #253 and #254 in all our processes.
View Safety Study


